1-8 of 8
Enzo Pavone
Close
Sort by
Journal Articles

Long-term outcome and prospective validation of NIH response criteria in 39 patients receiving imatinib for steroid-refractory chronic GVHD

Clinical Trials & Observations
Attilio Olivieri, Michele Cimminiello, Paolo Corradini, Nicola Mordini, Roberta Fedele, Carmine Selleri, Francesco Onida, Francesca Patriarca, Enzo Pavone, Silvia Svegliati, Armando Gabrielli, Paola Bresciani, Roberta Nuccorini, Sara Pascale, Sabrina Coluzzi, Fabrizio Pane, Antonella Poloni, Jacopo Olivieri, Pietro Leoni, Andrea Bacigalupo
Journal: Blood
Blood (2013) 122 (25): 4111–4118.
https://doi.org/10.1182/blood-2013-05-494278
Published: 2013
Includes: Supplemental data
Journal Articles

Clinical and Molecular Results of the Multicenter Randomized GITMO-IIL Trial in Poor Risk Follicular Lymphoma (FL) at Diagnosis: Rituximab-Supplemented High-Dose Sequential Chemotherapy (R-HDS) Is Superior to CHOP-R in Molecular Remissions Rate, EFS and PFS.

Marco Ladetto, MD, Federica de Marco, MD, Fabio Benedetti, MD, Umberto Vitolo, MD, Caterina Patti, MD, Alessandro Rambaldi, MD, Anna Marina Liberati, MD, Maurizio Musso, MD, Alessandro Pulsoni, MD, Attilio Olivieri, MD, Enzo Pavone, MD, Enrico Pogliani, MD, Delia Rota Scalabrini, MD, Andrea Gallamini, MD, Vincenzo Callea, MD, Irene Ricca, MD, Mario Boccadoro, MD, Ignazio Majolino, MD, Paolo Corradini, MD, Alessandro M. Gianni, MD, Corrado Tarella, MD
Journal: Blood
Blood (2006) 108 (11): 325.
https://doi.org/10.1182/blood.V108.11.325.325
Published: 2006
Journal Articles

Rituximab-Supplemented High-Dose Sequential Chemotherapy (HDS) Has Superior Response Rate and Event-Free Survival (EFS) Compared to R-CHOP in Poor Risk Follicular Lymphoma (FL) at Diagnosis: Results from a Multicenter Randomized GITMO Trial.

Marco Ladetto, MD, Irene Ricca, MD, Fabio Benedetti, MD, Umberto Vitolo, MD, Caterina Patti, MD, Alessandro Rambaldi, MD, Anna Marina Liberati, MD, Maurizio Musso, MD, Alessandro Pulsoni, MD, Attilio Olivieri, MD, Enzo Pavone, MD, Enrico Pogliani, MD, Delia Rota Scalabrini, MD, Andrea Gallamini, MD, Vincenzo Callea, MD, Barbara Mantoan, PhD, Mario Boccadoro, MD, Ignazio Majolino, MD, Paolo Corradini, MD, Alessandro M. Gianni, MD, Corrado Tarella, MD
Journal: Blood
Blood (2005) 106 (11): 675.
https://doi.org/10.1182/blood.V106.11.675.675
Published: 2005
Journal Articles

Effect of Adding Rituximab (R) to Induction Treatment and High Dose Chemotherapy (HDC) Prior to Autologous Stem Cell Transplantation (ASCT) as First Line Therapy in Stage III-IV Diffuse Large B-Cell Lymphoma (B-DLCL) at Poor Prognosis.

Umberto Vitolo, Giuseppe Rossi, Maria Giuseppina Cabras, Anna Marina Liberati, Annalisa Chiappella, Alessandro Levis, Enzo Pavone, Emanuele Angelucci, Barbara Botto, Manuela Ceccarelli, Roberto Freilone, Gianluca Gaidano, Domenico Novero, Lorella Orsucci, Isabella Palumbo, Enrico Pogliani, Delia Rota Scalabrini, Flavia Salvi, Anna Tonso, Alessandra Tucci, Eugenio Gallo
Journal: Blood
Blood (2005) 106 (11): 676.
https://doi.org/10.1182/blood.V106.11.676.676
Published: 2005
Journal Articles

Concurrent Rituximab with Dose-Dense MegaCEOP Chemotherapy and High Dose Mitoxantrone, Ara-C and Dexamethasone (MAD) Followed by BEAM and Autologous Stem Cell Transplantation (ASCT) Is Feasible and Effective in High Risk Diffuse Large B-Cell Lymphoma (B-DLCL): A Multicenter Pilot Study.

Umberto Vitolo, Anna Marina Liberati, Maria Giuseppina Cabras, Giuseppe Rossi, Alessandro Levis, Enzo Pavone, Emanuele Angelucci, Carola Boccomini, Lisa Bonello, Barbara Botto, Annalisa Chiappella, Francesco Di Vito, Isabella Palumbo, Enrico Pogliani, Delia Rota-Scalabrini, Flavia Salvi, Anna Tonso, Alessandra Tucci, Eugenio Gallo
Journal: Blood
Blood (2004) 104 (11): 1321.
https://doi.org/10.1182/blood.V104.11.1321.1321
Published: 2004
Journal Articles

Elderly Aggressive-Histology Non-Hodgkin’s Lymphoma: First-Line VNCOP-B Regimen Experience on 350 Patients

Pier Luigi Zinzani, Sergio Storti, Alfonso Zaccaria, Luciano Moretti, Massimo Magagnoli, Enzo Pavone, Patrizia Gentilini, Luciano Guardigni, Marco Gobbi, Pier Paolo Fattori, Brunangelo Falini, Vito Michele Lauta, Maurizio Bendandi, Filippo Gherlinzoni, Amalia De Renzo, Francesco Zaja, Patrizio Mazza, Ettore Volpe, Monica Bocchia, Enrico Aitini, Maurizio Tabanelli, Giuseppe Leone, Sante Tura
Journal: Blood
Blood (1999) 94 (1): 33–38.
https://doi.org/10.1182/blood.V94.1.33.413k08_33_38
Published: 1999
Journal Articles

Anaplastic Large Cell Lymphoma Hodgkin's-Like: A Randomized Trial of ABVD Versus MACOP-B With and Without Radiation Therapy

Pier Luigi Zinzani, Maurizio Martelli, Massimo Magagnoli, Alfonso Zaccaria, Fioravante Ronconi, Maria Cantonetti, Monica Bocchia, Roberto Marra, Marco Gobbi, Brunangelo Falini, Filippo Gherlinzoni, Luciano Moretti, Amalia De Renzo, Patrizio Mazza, Enzo Pavone, Elena Sabattini, Angela Amendola, Maurizio Bendandi, Stefano A. Pileri, Franco Mandelli, Sante Tura
Journal: Blood
Blood (1998) 92 (3): 790–794.
https://doi.org/10.1182/blood.V92.3.790
Published: 1998
Journal Articles

Randomized Trial With or Without Granulocyte Colony-Stimulating Factor as Adjunct to Induction VNCOP-B Treatment of Elderly High-Grade Non-Hodgkin's Lymphoma

Pier Luigi Zinzani, Enzo Pavone, Sergio Storti, Luciano Moretti, Pier Paolo Fattori, Luciano Guardigni, Brunangelo Falini, Marco Gobbi, Patrizia Gentilini, Vito Michele Lauta, Maurizio Bendandi, Filippo Gherlinzoni, Massimo Magagnoli, Stefamia Venturi, Enrico Aitini, Maurizio Tabanelli, Giuseppe Leone, Vincenzo Liso, Sante Tura
Journal: Blood
Blood (1997) 89 (11): 3974–3979.
https://doi.org/10.1182/blood.V89.11.3974
Published: 1997